Científicos identifican el circuito cerebral que causa la transición al dolor crónico

Investigadores de la Universidad de Colorado en Boulder han identificado una región cerebral llamada corteza insular granular caudal (CGIC, por sus siglas en inglés) que actúa como un interruptor que convierte el dolor agudo en dolor crónico. En estudios con animales, desactivar este circuito evitó que el dolor crónico se desarrollara o lo revirtió una vez establecido. Los hallazgos, publicados en el Journal of Neuroscience, abren camino a nuevos tratamientos más allá de los opioides.

Un equipo dirigido por Linda Watkins, profesora distinguida de neurociencia del comportamiento en la Universidad de Colorado en Boulder, estudió la CGIC en ratas con lesiones en el nervio ciático. Utilizaron métodos quimiogenéticos avanzados y proteínas fluorescentes para rastrear y silenciar neuronas específicas. Apagar la vía de la CGIC evitó que las señales de dolor persistieran después de que la lesión sanara, eliminando síntomas como la alodinia, donde un toque ligero resulta doloroso. Watkins afirmó: 'Si se silencia a este decisivo regulador, el dolor crónico no ocurre. Si ya está presente, el dolor crónico desaparece'.

Artículos relacionados

Illustration of distant astrocytes signaling via CCN1 protein to enhance microglia debris clearance in mouse spinal cord injury.
Imagen generada por IA

Cedars-Sinai study maps how distant astrocytes help microglia clear debris after spinal cord injury

Reportado por IA Imagen generada por IA Verificado por hechos

Scientists at Cedars-Sinai Medical Center report that a subset of astrocytes located away from a spinal cord injury can help drive repair in mice by releasing the protein CCN1, which alters microglia metabolism to improve cleanup of lipid-rich nerve debris. The work, published in Nature, also found evidence of a similar CCN1-linked response in human spinal cord tissue from people with multiple sclerosis.

Researchers at the University of Technology Sydney report that inducing localized inflammation in a striatal region involved in action selection pushed rats toward more goal-directed, outcome-sensitive behavior rather than automatic habits. The team traced the effect to disrupted astrocyte function, a finding they say could inform future approaches to compulsive disorders such as OCD and addiction.

Reportado por IA

Researchers are revisiting substance P, a neuropeptide linked to migraine pain, after it was dismissed as a treatment target 25 years ago. A recent study shows it causes headaches and blood vessel dilation in both migraine sufferers and others, suggesting potential for new therapies. This comes amid advances in blocking other migraine-related peptides like CGRP and PACAP.

Researchers at Oregon Health & Science University have pinpointed specific sites on NMDA receptors targeted by harmful antibodies in a rare autoimmune brain disorder known as "Brain on Fire." This discovery, published in Science Advances, could lead to more precise treatments and earlier detection. The condition affects about 1 in 1 million people annually, mainly young adults, causing severe symptoms like seizures and memory loss.

Reportado por IA

Researchers have discovered that psychedelic substances suppress visual processing in the brain, leading to hallucinations by drawing on memory fragments. The study, conducted using advanced imaging on mice, shows how slow brain waves shift perception toward internal recall. These findings could inform therapies for depression and anxiety.

Este sitio web utiliza cookies

Utilizamos cookies para análisis con el fin de mejorar nuestro sitio. Lee nuestra política de privacidad para más información.
Rechazar